文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

高龄老人的癌症负担更新情况:一项基于2022年全球癌症负担估计数据的人群研究。

Updated cancer burden in oldest old: A population-based study using 2022 Globocan estimates.

作者信息

Shah Richa, Battisti Nicolò Matteo Luca, Brain Etienne, Gnangnon Freddy H R, Kanesvaran Ravindran, Mohile Supriya, Noronha Vanita, Puts Martine, Soto-Perez-de-Celis Enrique, Pilleron Sophie

机构信息

Cancer Surveillance Branch, International Agency for Research on Cancer, 25 Avenue Tony Garnier CS 90627, Lyon 69366, France.

Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK and International Society of Geriatric Oncology, Geneva, Switzerland.

出版信息

Cancer Epidemiol. 2025 Apr;95:102716. doi: 10.1016/j.canep.2024.102716. Epub 2024 Nov 26.


DOI:10.1016/j.canep.2024.102716
PMID:39603975
Abstract

BACKGROUND: The global population aged 80 years or older is expected to triple by 2050, leading to an increased cancer burden in the oldest population. This study describes the estimated cancer incidence and mortality in 2022 and projections for 2050 in the oldest old, analyzed globally and by world regions and World Bank income levels, for all sexes combined, as well as separately for males and females. METHODS: Using GLOBOCAN 2022 estimates, we reported the estimated number of new cancer cases (excluding non-melanoma skin cancers), deaths, and truncated age-standardized incidence (ASIR) and mortality rates (ASMR) (per 100,000 individuals aged 80 years or older). We also presented the top five cancers by cases and deaths. Additionally, we projected the number of new cancer cases and deaths for each region in 2050, assuming no change in cancer incidence and death rates. RESULT: In 2022, an estimated 2.6 million new cancer cases (14 % of all cancer cases) and 2.1 million cancer deaths (22 % of all cancer deaths) occurred in the oldest old, with regional variations. Globally, lung, colorectal, and prostate cancers were the most common cancers diagnosed and leading causes of cancer death. ASIR ranged from 987 in Africa to 2044 per 100,000 in Northern America while ASMR ranged from 981 in Africa to 1769 per 100,000 in Oceania. In 2050, an estimated 7.4 million new cancer cases and 6 million cancer deaths are expected. The greatest increases are anticipated in China, India, and Africa, with increases exceeding 200 % compared to 2022 estimates. CONCLUSION: The growing cancer burden among the oldest old poses significant challenges to global healthcare systems, necessitating resource-tailored adaptations. These findings call for the inclusion of the oldest old in the development and implementation of cancer control policies and a better representation in cancer research.

摘要

背景:预计到2050年,全球80岁及以上的老年人口数量将增至三倍,这将导致最年长人群的癌症负担加重。本研究描述了2022年80岁及以上老年人的癌症发病率和死亡率估计情况,以及对2050年的预测,分析范围覆盖全球、世界各区域和世界银行划分的收入水平,涵盖所有性别,以及男性和女性的单独情况。 方法:使用全球癌症数据库(GLOBOCAN)2022年的估计数据,我们报告了新癌症病例(不包括非黑色素瘤皮肤癌)、死亡人数的估计数量,以及截断年龄标准化发病率(ASIR)和死亡率(ASMR)(每10万名80岁及以上个体)。我们还列出了病例数和死亡人数最多的五种癌症。此外,我们假设癌症发病率和死亡率不变,预测了2050年每个区域的新癌症病例数和死亡人数。 结果:2022年,80岁及以上老年人估计有260万例新癌症病例(占所有癌症病例的14%)和210万例癌症死亡(占所有癌症死亡的22%),存在区域差异。在全球范围内,肺癌、结直肠癌和前列腺癌是最常见的诊断癌症和癌症死亡的主要原因。ASIR范围从非洲的每10万人987例到北美洲的每10万人2044例,而ASMR范围从非洲的每10万人981例到大洋洲的每10万人1769例。预计到2050年,新癌症病例数将达740万例,癌症死亡人数将达600万例。中国、印度和非洲的增长幅度最大,与2022年的估计相比,增幅超过200%。 结论:最年长人群中不断增加的癌症负担给全球医疗系统带来了重大挑战,需要根据资源进行调整。这些发现呼吁将最年长人群纳入癌症控制政策的制定和实施过程,并在癌症研究中得到更好的体现。

相似文献

[1]
Updated cancer burden in oldest old: A population-based study using 2022 Globocan estimates.

Cancer Epidemiol. 2025-4

[2]
Global esophageal cancer epidemiology in 2022 and predictions for 2050: A comprehensive analysis and projections based on GLOBOCAN data.

Chin Med J (Engl). 2024-12-20

[3]
Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050.

Int J Cancer. 2021-2-1

[4]
Burden of Stomach Cancer Incidence, Mortality, Disability-Adjusted Life Years, and Risk Factors in 204 Countries, 1990-2019: An Examination of Global Burden of Disease 2019.

J Gastrointest Cancer. 2024-6

[5]
Cancer incidence and mortality estimates in 2022 in southeast Asia: a comparative analysis.

Lancet Oncol. 2025-4

[6]
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

CA Cancer J Clin. 2021-5

[7]
The current and future global burden of cancer among adolescents and young adults: a population-based study.

Lancet Oncol. 2024-12

[8]
Global cancer statistics for adolescents and young adults: population based study.

J Hematol Oncol. 2024-10-21

[9]
Global burden of gynaecological cancers in 2022 and projections to 2050.

J Glob Health. 2024-8-16

[10]
Mapping of global, regional and national incidence, mortality and mortality-to-incidence ratio of lung cancer in 2020 and 2050.

Int J Clin Oncol. 2022-4

引用本文的文献

[1]
Advances in research on RNA methylation and cancer radiotherapy resistance.

Front Oncol. 2025-7-31

[2]
SBRT in the Very Elderly: A Viable Option for Pulmonary Oligometastases?

Cancers (Basel). 2025-7-30

[3]
Temporal trends in the burden of tracheal, bronchial, and lung cancer in China and globally: A comprehensive analysis from 1990 to 2021.

Chin Med J Pulm Crit Care Med. 2025-6-10

[4]
Immune Checkpoint Inhibitors in the Treatment of Advanced Melanoma in Older Patients: An Overview of Published Data.

Cancers (Basel). 2025-5-30

[5]
Quantifying the burden of cancer in Puerto Rico's oldest residents.

Cancer Epidemiol. 2025-8

[6]
Piperazine-Substituted Pyranopyridines Exhibit Antiproliferative Activity and Act as Inhibitors of HBV Virion Production.

Int J Mol Sci. 2025-4-23

[7]
Cancer prevention: past challenges and future directions.

Genes Environ. 2025-2-27

[8]
Epidemiology of cancer in older adults: a systematic review of age-related differences in solid malignancies treatment.

Curr Oncol Rep. 2025-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索